CLYM (Climb Bio Inc.) Sof foyda

CLYM (Climb Bio) - kompaniyaning tovar belgisi

Climb Bio Inc (CLYM) samarali uzoq muddatli yechimlar yetishmovchiligi sharoitida immun tizimi buzilishlariga qarshi kurashish usullarini ishlab chiqayotgan biotexnologiya kompaniyasidir. Ushbu grafikda kuzatilayotgan aktiv qiymati -0.06 miqdorida qat'iy belgilangan bo'lib, u foyda dinamikasini aks ettiradi. Korxonaning moliyaviy muvaffaqiyati og'ir patologiyalarga chalingan shaxslar uchun B-limfotsit terapiyasining samaradorligiga bog'liq bo'lib, bunda sug'urta provayderlari asosiy to'lov manbalari vazifasini bajaradi.

CLYM (Climb Bio Inc) Sof foyda tarixi 04.10.2024dan 29.10.2026gacha

Climb Bio (CLYM) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Climb Bio, Inc|CLYM - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Climb Bio, Inc|CLYM - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Climb Bio|CLYM - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi climbbio.com|CLYM - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Climb Bio Inc|CLYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Climb Bio Inc.|CLYM - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Climb Bio, Inc|CLYM - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Climb Bio|Shoshilinch likvidlik climbbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CLYM - Sof foyda
Kompaniyaning jamlanma tahlili:Climb Bio Inc
Climb Bio, Inc. asosiy tovari

Geopolitik to'siqlar va sanksiyalar Climb Bio Inc (CLYM) kompaniyasiga kimyoviy moddalar va xalqaro sinovlardan foydalanish imkoniyatini cheklamoqda. Ushbu narx harakati bevosita kompaniyaning sof foydasi dinamikasini aks ettirib, kapital harakatining haqiqiy impulsini ko'rsatmoqda. Ushbu ko'rsatkichning barqaror platosi mablag'larning muzlatilishi ehtimolini signalizatsiya qilib, uzoq muddatli pasayish xavflarini yashirmoqda. Ushbu indikator spekulyatsiyalarni bartaraf etib, haqiqiy foyda vektorini ochib beradi. Bu yerdagi gorizontal tendentsiya yo yulochilikni, yoki chuqur likvidlik inqirozini bashorat qiladi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Pharming Corp (PHAR) - Sof daromad|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|UPB (upstreambio.com) - Kompaniyaning sof foydasi|ZBIO (Zenas Biopharma) - Sof foyda|Immunome Inc (IMNM) - Sof moliyaviy natija|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|Sof daromad KalVista Corp KALV|Sof foyda SEPN (Septerna Inc)|pieris.com - Kompaniyaning sof foydasi|SVRA: Sof daromad|Yakuniy foyda RIGL (Rigel Pharma)|ANAB: Sof foyda|ATXS (Astria Corp) - Kompaniyaning sof foydasi|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS - Kompaniyaning sof daromadi|Kyverna - Sof daromad|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|Sof moliyaviy natija ventyxbio.com VTYX|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Kompaniya foydasi AVTX|ELDN (Eledon) - Sof foyda|Sof daromad Agenus, Inc (AGEN)|Sof foyda ZURA|Sof daromad atyrpharma.com ATYR|Kompaniyaning sof foydasi Adagene Inc. ADAG|ImageneBio - Kompaniyaning sof foydasi|STTK: Sof daromad|Kompaniyaning sof daromadi Equillium, Inc.|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Sof daromad Immunic|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|InflaRx GmbH - Soliqdan keyingi foyda|Sof foyda XFOR|ACET (adicetbio.com) - Yakuniy foyda|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|BRNS - Kompaniyaning sof foydasi|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Sof daromad Akari Therapeutics, Plc|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Sof foyda Q32 Bio Corp|Sof daromad GOVX (GeoVax)|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof moliyaviy natija Carisma Therapeutics Inc (CARM)|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|Sof daromad AIM|Sof foyda Aditxt Corp|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|xortx.com - Kompaniya foydasi|Sof foyda HIND (Vyome Holdings)|Revelation Biosciences Inc (REVB) - Kompaniyaning sof daromadi|Indaptus - Sof foyda|BiondVax Pharmaceuticals (SCNI) - Sof daromad|calcimedica.com (CALI) - Kompaniyaning sof foydasi|AFMD (Affimed N.V.) - Kompaniyaning sof foydasi|ALLK (Allakos Inc) - Sof foyda|HOOKIPA (HOOK) - Sof moliyaviy natija|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com - Kompaniyaning sof foydasi|THRD: Sof daromad